THC & CBD
THC (Tetrahydrocannabinol):
THC is the primary psychoactive cannabinoid in the cannabis plant. It interacts with the CB1 receptors in the brain, leading to a range of effects such as euphoria, relaxation, and altered perception. THC is often associated with the “high” that people experience when consuming cannabis.
- Delta-9 THC (Delta-9 Tetrahydrocannabinol): Delta-9 THC is the primary psychoactive cannabinoid in the cannabis plant, and is responsible for the “high” that people experience. It may have potential as a pain reliever, appetite stimulant, and anti-nausea agent.
- Delta-8 THC (Delta-8 Tetrahydrocannabinol): Delta-8 THC is a psychoactive cannabinoid that may have potential as a pain reliever and anti-nausea agent.
- THC-A (Tetrahydrocannabinolic acid): THC-A is the precursor to THC, and is non-psychoactive. It may have potential as an anti-inflammatory and neuroprotective agent.
- THCV (Tetrahydrocannabivarin): THCV is a psychoactive cannabinoid that may have appetite-suppressing properties. It may also have potential as a treatment for conditions such as diabetes and anxiety.
- THCA-V (Tetrahydrocannabivarinic acid): THCA-V is a non-psychoactive cannabinoid that may have potential as an appetite suppressant.
CBD (Cannabidiol and other Cannabinoids):
CBD is a non-psychoactive cannabinoid that is found in the cannabis plant. It interacts with the body’s endocannabinoid system, which is involved in regulating a range of processes such as mood, appetite, and sleep. CBD has been shown to have a range of potential health benefits, such as reducing anxiety, relieving pain, and improving sleep.
Other cannabinoids:
In addition to THC and CBD, the cannabis plant contains a number of other cannabinoids that may have therapeutic benefits. Here are a few examples:
- CBC (Cannabichromene): CBC is a non-psychoactive cannabinoid that may have anti-inflammatory and analgesic properties. It may also have potential as a treatment for conditions such as acne and depression.
- CBCA (Cannabichromenic acid): CBCA is the precursor to CBC, and is non-psychoactive. It may have potential as an anti-inflammatory and anti-fungal agent.
- CBD-A (Cannabidiolic acid): CBD-A is the precursor to CBD, and is non-psychoactive. It may have potential as an anti-inflammatory and anti-nausea agent.
- CBDV (Cannabidivarin): CBDV is a non-psychoactive cannabinoid that may have potential as an anti-convulsant and anti-inflammatory agent.
- CBG (Cannabigerol): CBG is a non-psychoactive cannabinoid that may have anti-inflammatory and antibacterial properties. It may also have potential as a treatment for conditions such as glaucoma and inflammatory bowel disease.
- CBN (Cannabinol): CBN is a mildly psychoactive cannabinoid that is produced when THC is exposed to oxygen. It may have sedative properties and may be useful for treating conditions such as insomnia and pain.
CBD also vital in the chemical composition/profile of a strain can be added to Organic THC distillate oil products to enhance the overall experience in several ways. We create our product to give you the full expected experience. Here are a few examples:
Balancing effects: THC is the primary psychoactive cannabinoid in cannabis, while CBD is non-psychoactive and has a range of therapeutic benefits.
When CBD distillate is added to a THC-dominant product, it can balance the effects of THC, providing a more balanced and less intense experience. This can be particularly helpful for consumers who are new to cannabis or who are sensitive to the effects of THC.
Reducing anxiety: CBD has been shown to have anxiolytic (anti-anxiety) effects, and adding CBD distillate to a cannabis product can help reduce the anxiety and paranoia that can sometimes accompany the use of THC. This can be particularly helpful for consumers who are prone to anxiety or who have had negative experiences with THC in the past.
Pain relief: CBD has analgesic (pain-relieving) properties and can enhance the pain-relieving effects of THC. Adding CBD distillate to a cannabis product can help provide more comprehensive relief for pain and inflammation.
Anti-inflammatory effects: CBD has been shown to have potent anti-inflammatory effects, and adding CBD distillate to a cannabis product can enhance these effects. This can be particularly helpful for consumers who suffer from conditions that involve inflammation, such as arthritis or inflammatory bowel disease.
It’s important to note that the effects of CBD can vary depending on the dose, the method of administration, and the individual’s unique physiology. When adding CBD distillate to a cannabis product, it’s important to use the appropriate dose to achieve the desired effects. A knowledgeable bud-tender or healthcare professional can help provide guidance on how to use CBD distillate to enhance the overall cannabis experience.
| Cannabinoid | Effects | Common Sources |
| THC (Δ9-tetrahydrocannabinol) | Euphoric, psychoactive, analgesic, anti-inflammatory, anti-nausea, appetite stimulant | Cannabis (mostly in marijuana strains) |
| CBD (cannabidiol) | Anti-inflammatory, analgesic, anti-anxiety, anti-psychotic, neuroprotective, anti-epileptic | Hemp, cannabis (mostly in CBD-dominant strains) |
| CBG (cannabigerol) | Anti-inflammatory, antibacterial, neuroprotective, analgesic | Cannabis (mostly in low-THC strains) |
| CBN (cannabinol) | Sedative, analgesic, anti-inflammatory | Aged cannabis, cannabis exposed to oxygen |
| CBC (cannabichromene) | Anti-inflammatory, analgesic, anti-fungal, anti-depressant | Cannabis (mostly in low-THC strains) |
| THCV (tetrahydrocannabivarin) | Appetite suppressant, anti-convulsant, bone growth stimulant | Cannabis (mostly in African strains) |
| Delta-8-THC (delta-8-tetrahydrocannabinol) | Psychoactive, anti-nausea, anti-anxiety, pain-relieving | Cannabis (can be produced from hemp-derived CBD) |
| THCA (tetrahydrocannabinolic acid) | Non-psychoactive precursor to THC with potential anti-inflammatory, anti-tumour properties | Raw cannabis |
| CBDA (cannabidiolic acid) | Non-psychoactive precursor to CBD with potential anti-inflammatory, antibacterial, and analgesic properties | Raw cannabis, hemp |
Ratios THC:CBD
The ratio of THC to CBD can have a significant impact on the psychoactive effects of the product. Higher ratios of THC to CBD can result in more intense and euphoric effects, while higher ratios of CBD to THC can result in more calming and relaxing effects. A 1:1 ratio is often used to provide a balanced and synergistic effect of both cannabinoids.
Adding terpene profiles can further enhance the effects of the product.
Pain Relief: Both THC and CBD have analgesic properties, and a combination of the two can provide more comprehensive relief for pain and inflammation. When THC and CBD are combined in equal ratios or with a higher CBD content, it has been found to be effective in reducing neuropathic and chronic pain. Certain terpene profiles can also be added for more targeted pain relief.
Anxiety: CBD has been shown to have anxiolytic (anti-anxiety) effects, and a higher ratio of CBD to THC can reduce anxiety and paranoia. A higher CBD ratio can provide a more calming effect, while a higher THC ratio can lead to increased anxiety.
Anti-inflammatory: Both THC and CBD have anti-inflammatory properties, and the combination of the two can be particularly effective in reducing inflammation.
Terpenes such as Pinene, Linalool, and Limonene can also be added to further enhance the anti-inflammatory effects.
Neuroprotective: Both THC and CBD have neuroprotective properties and can potentially help prevent brain cell damage caused by inflammation and oxidative stress. The combination of the two cannabinoids in equal ratios has been shown to have the potential to improve cognitive function and protect against neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Here are some examples of the THC:CBD ratios that have been used in medicine for certain ailments:
Multiple sclerosis (MS): A 1:1 ratio of THC to CBD has been shown to be effective in reducing muscle spasticity and pain in patients with MS.
Chronic pain: A 1:1 ratio of THC to CBD has been found to be effective in reducing chronic pain caused by conditions such as neuropathy, fibromyalgia, and arthritis.
Epilepsy: In clinical trials, a 20:1 ratio of CBD to THC was found to be effective in reducing the frequency and severity of seizures in patients with severe forms of epilepsy, such as Dravet syndrome and Lennox-Gastaut syndrome.
Anxiety: A higher CBD ratio (e.g. 3:1 or 4:1 CBD to THC) has been found to be effective in reducing anxiety and promoting relaxation without causing the psychoactive effects associated with high THC doses.
Cancer: A 1:1 ratio of THC to CBD has been used in cancer patients to reduce pain, nausea, and vomiting associated with chemotherapy.
It’s important to note that the optimal THC:CBD ratio can vary depending on the individual’s unique physiology and the specific ailment being treated. Additionally, terpene profiles can also play a significant role in the effects and health benefits of a cannabis product. Therefore, it’s important to consult with a healthcare professional or knowledgeable bud-tender to determine the appropriate ratio and terpene profile for an individual’s needs and preferences.
